Only in Titles

Search results for: Hydroxyurea CAS Number [127 07 1]

paperclip

#24227514   // To Up

[Effectiveness and acceptance of hydroxyurea in the treatment of severe forms of sickle cell disease: a prospective study of 65 cases].

Sickle cell disease is a serious illness by its complications. For the severe forms, three therapeutic options are actually allowed: transfusion therapy, hydroxyurea and bone marrow transplantation. aim: To evaluate the contribution of hydroxyurea in the management of severe forms of sickle cell disease. methods: It is a prospective study carried out a period of 11 years in "Centre National de Greffe de Moelle Osseuse" of Tunis. They were 65 patients divided into 38 homozygote forms and 27 double heterozygous composite S/β thalassemics. The mean age was 130 months. The failure criterion of the treatment was hospitalization duration more than 15 days/ patient / year or the occurrence of a severe complication of the disease. results: The main indications of hydroxyurea were the prevention of the recidivism of an acute chest syndrome in 8 cases, iterative painful crises, more than 3 events per year, in 53 cases and anemic forms of the disease in 4 cases. We have observed, a rapid and durable improvement in the clinical manifestations and a significant fall of the number of hospitalization days / patient/year from 25.2 days to 2.6 days (p<0.001). The treatment was well tolerated. The rates of foetal hemoglobin have significantly increased from 6.4 to 27.45 % (p<0.001), of hemoglobin from 7.6 to 9.4 g/dl(p<0.001), of the mean corpuscular volume from 80.3 to 99.1 fl (p<0.001), and a significant fall of the white blood cell rate from 15077 to 8170/mm3 (p<0.001), of polynuclear neutrophils from 8015 to 3509/mm3 (p<0.001), and reticulocytes from 693736 to 209837 /mm3(p<0.001) was observed.Ten patients were considered as treatment failure with a failure rate of 15.3%. The main failure etiology was represented with bad observance.
Fethi Mellouli, Samah Chouaibi, Naouel Dhouib, Monia Ouederni, Monia Ben Khaled, Salem Abbes, Mohamed Bejaoui

1889 related Products with: [Effectiveness and acceptance of hydroxyurea in the treatment of severe forms of sickle cell disease: a prospective study of 65 cases].



Related Pathways

paperclip

#18164913   2007/12/31 To Up

[The use of hydroxyurea in severe forms of sickle cell disease: study of 47 Tunisian paediatric cases].

The Sickle Cell Disease (SCD) is a serious illness considering its complications. For the children seriously affected, three therapeutic options are currently validated: transfusion therapy, hydroxyurea and bone-marrow transplantation.
F Mellouli, M Bejaoui

1548 related Products with: [The use of hydroxyurea in severe forms of sickle cell disease: study of 47 Tunisian paediatric cases].

5 G

Related Pathways

paperclip

#11048406   // To Up

[Hematologic and cytogenetic response to treatment in patients with chronic myeloid leukemia].

The Interferon alpha therapy increases the number of cytogenetic responses in patients with chronic myeloic leukaemia. The addition of cytarabine can reduce the number of Ph positive metaphases. The achievement of cytogenetic response is connected with longer survival of patients with chronic myeloic leukaemia. The aim of the study was the evaluation of the achievement of hematologic and cytogenetic response as well as adverse effects of the treatment in chronic myeloic leukaemia patients.
E Tóthová, M Fricová, N Stecová, A Kafková, B Mudronová, E Svorcová, T Guman, S Raffac, M Hlebasková

2761 related Products with: [Hematologic and cytogenetic response to treatment in patients with chronic myeloid leukemia].

100 50 UG96 wells (1 kit)1 mg500 gm.1mg100

Related Pathways